These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1540229)

  • 1. A possible mechanism of the impairment of hepatic microsomal monooxygenase activities after multiple administration of propranolol in rats.
    Masubuchi Y; Suzuki K; Fujita S; Suzuki T
    Biochem Pharmacol; 1992 Feb; 43(4):757-62. PubMed ID: 1540229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of rat cytochrome P450 2D enzyme by a further metabolite of 4-hydroxypropranolol, the major and active metabolite of propranolol.
    Narimatsu S; Arai T; Masubuchi Y; Horie T; Hosokawa M; Ueno K; Kataoka H; Yamamoto S; Ishikawa T; Cho AK
    Biol Pharm Bull; 2001 Sep; 24(9):988-94. PubMed ID: 11558582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impairment of debrisoquine 4-hydroxylase and related monooxygenase activities in the rat following treatment with propranolol.
    Masubuchi Y; Fujita S; Chiba M; Kagimoto N; Umeda S; Suzuki T
    Biochem Pharmacol; 1991 Mar 15-Apr 1; 41(6-7):861-5. PubMed ID: 2009081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the CYP2D subfamily in metabolism-dependent covalent binding of propranolol to liver microsomal protein in rats.
    Masubuchi Y; Narimatsu S; Hosokawa S; Suzuki T
    Biochem Pharmacol; 1994 Nov; 48(10):1891-8. PubMed ID: 7986200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of propranolol and irreversible binding to rat liver microsomes: strain differences and effects of inhibitors.
    Masubuchi Y; Narimatsu S; Suzuki T
    Biochem Pharmacol; 1992 Feb; 43(3):635-7. PubMed ID: 1540217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucuronidation of propranolol and 4'-hydroxypropranolol. Substrate specificity and stereoselectivity of rat liver microsomal glucuronyltransferases.
    Thompson JA; Hull JE; Norris KJ
    Drug Metab Dispos; 1981; 9(5):466-71. PubMed ID: 6117447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic analysis of propranolol-induced impairment of its own metabolism in rats.
    Kagimoto N; Masubuchi Y; Fujita S; Narimatsu S; Suzuki T
    J Pharm Pharmacol; 1994 Jun; 46(6):528-30. PubMed ID: 7932057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covalent binding of a reactive metabolite derived from propranolol and its active metabolite 4-hydroxypropranolol to hepatic microsomal proteins of the rat.
    Narimatsu S; Arai T; Watanabe T; Masubuchi Y; Horie T; Suzuki T; Ishikawa T; Tsutsui M; Kumagai Y; Cho AK
    Chem Res Toxicol; 1997 Mar; 10(3):289-95. PubMed ID: 9084908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (S)-4'-hydroxypropranolol causes product inhibition and dose-dependent bioavailability of propranolol enantiomers in the isolated perfused rat liver and in rat liver microsomes.
    Nand RA; Ghabrial H; Smallwood RA; Morgan DJ
    Xenobiotica; 1996 Dec; 26(12):1249-61. PubMed ID: 9004455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase.
    Masubuchi Y; Hosokawa S; Horie T; Suzuki T; Ohmori S; Kitada M; Narimatsu S
    Drug Metab Dispos; 1994; 22(6):909-15. PubMed ID: 7895609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of CYP2D6 activity by treatment with propranolol and the role of 4-hydroxy propranolol.
    Rowland K; Yeo WW; Ellis SW; Chadwick IG; Haq I; Lennard MS; Jackson PR; Ramsay LE; Tucker GT
    Br J Clin Pharmacol; 1994 Jul; 38(1):9-14. PubMed ID: 7946944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic basis for the non-linearity of hepatic elimination of propranolol in the isolated perfused rat liver.
    Ishida R; Suzuki K; Masubuchi Y; Narimatsu S; Fujita S; Suzuki T
    Biochem Pharmacol; 1992 Dec; 44(12):2281-8. PubMed ID: 1472093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic activation of lidocaine and covalent binding to rat liver microsomal protein.
    Masubuchi Y; Araki J; Narimatsu S; Suzuki T
    Biochem Pharmacol; 1992 Jun; 43(12):2551-7. PubMed ID: 1632813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of D,L-4-hydroxypropranolol on the thyroxine to 3,5,3'-triiodothyronine conversion in rat renal and liver microsomes.
    Jørgensen PH; Lumholtz IB; Faber J; Kirkegaard C; Siersbaek-Nielsen K; Friis T
    Acta Endocrinol (Copenh); 1984 Feb; 105(2):205-10. PubMed ID: 6695551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a chemically reactive propranolol metabolite that binds to microsomal proteins of rat liver.
    Narimatsu S; Watanabe T; Masubuchi Y; Horie T; Kumagai Y; Cho AK; Imaoka S; Funae Y; Ishikawa T; Suzuki T
    Chem Res Toxicol; 1995; 8(5):721-8. PubMed ID: 7548755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regioselective contribution of the cytochrome P-450 2D subfamily to propranolol metabolism in rat liver microsomes.
    Masubuchi Y; Kagimoto N; Narimatsu S; Fujita S; Suzuki T
    Drug Metab Dispos; 1993; 21(6):1012-6. PubMed ID: 7905378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 isozymes catalyzing 4-hydroxylation of parkinsonism-related compound 1,2,3,4-tetrahydroisoquinoline in rat liver microsomes.
    Suzuki T; Fujita S; Narimatsu S; Masubuchi Y; Tachibana M; Ohta S; Hirobe M
    FASEB J; 1992 Jan; 6(2):771-6. PubMed ID: 1537468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibition of rat hepatic microsomal propranolol metabolism by a covalently bound reactive metabolite.
    Pritchard JF; Schneck DW; Hayes AH
    Res Commun Chem Pathol Pharmacol; 1980 Feb; 27(2):211-22. PubMed ID: 6768117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New heterocyclic modifiers of oxidative drug metabolism--II. Steric factors in the interaction of isomeric 2-(naphthyl)methylbenzimidazoles with rat hepatic microsomal cytochrome P-450 and monooxygenase activities.
    Murray M
    Biochem Pharmacol; 1987 Feb; 36(4):463-8. PubMed ID: 3493778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monooxygenase-mediated activation of chlorotrianisene (TACE) in covalent binding to rat hepatic microsomal proteins.
    Juedes MJ; Bulger WH; Kupfer D
    Drug Metab Dispos; 1987; 15(6):786-93. PubMed ID: 2893703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.